• Course

All audiences

Unit 5: Comorbidities and special situations - 1

Upon completion of this unit you should be able:

  • To learn the clinical and the laboratory assessment of the hypertensive patient
  • To learn the profiles of anti-hypertensive agents and judicious use of combinations
  • To learn the primary and secondary targets of lipid management in diabetes
  • To understand the therapeutic lifestyle changes that can impact lipid levels and the principles of pharmacological treatment of dyslipidaemia
  • To learn the difference between pregestational and gestational diabetes
  • To understand the best treatment options for diabetes in pregnancy
  • To learn about the kind of advice should be given to persons with pregestational and gestational diabetes after delivery
  • To learn about the glycaemic targets for the surgical patient
  • To understand the preoperative evaluation and the post-operative management of a patient with diabetes
  • To understand the rationale of selecting anti-diabetic agents for glycaemic control in patients with renal impairment
  • To understand the concept of new onset diabetes after transplant (NODAT) and its management
  • To understand the regulation of glucose metabolism in liver and learn about the treatment of diabetes in the presence of liver disease
  • To learn about the blood glucose targets in critically ill patients and to understand the anti-hyperglycaemic agents in hospitalized critically ill patients.
  • To understand bone pathology associated with diabetes and the effect of anti-diabetic therapy on bone health
  • To understand to diagnose and differentiate between various types of diabetes in young
  • To understand how the basic management of diabetes differs in elderly?
  • To learn about how thyroid disorder can affect diabetes
  • To learn the association between diabetes and cancer
  • To be aware of the association between other anti-diabetic medications and cancer.

Release date

16 Aug 2016